HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
D W Kufe Selected Research
D W Kufe Research Topics
Disease
13
Neoplasms (Cancer)
02/2013 - 01/2000
3
Breast Neoplasms (Breast Cancer)
02/2013 - 09/2000
1
Melanoma (Melanoma, Malignant)
04/2009
1
Adenocarcinoma
05/2001
1
Carcinoma (Carcinomatosis)
02/2001
1
Lewis Lung Carcinoma
09/2000
1
Prostatic Neoplasms (Prostate Cancer)
05/2000
1
Fever (Fevers)
05/2000
1
B-Cell Lymphoma (Lymphoma, B Cell)
04/2000
1
Smallpox (Variola)
03/2000
1
Poliomyelitis (Polio)
03/2000
1
Squamous Cell Carcinoma of Head and Neck
02/2000
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2000
Drug/Important Bio-Agent (IBA)
2
Proteins (Proteins, Gene)
FDA Link
02/2013 - 01/2006
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
04/2009 - 02/2003
2
Antigens
IBA
05/2001 - 09/2000
1
Mucin-1 (CA 15-3 Antigen)
IBA
02/2013
1
Oncogene Proteins (Oncogene Protein)
IBA
02/2013
1
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
04/2009
1
Type I Tumor Necrosis Factor Receptors
IBA
04/2009
1
Anti-Bacterial Agents (Antibiotics)
IBA
11/2001
1
DX 52-1
IBA
11/2001
1
Prodrugs
IBA
10/2001
1
Monoclonal Antibodies
IBA
05/2001
1
Epitopes
IBA
05/2001
1
Mucins
IBA
05/2001
1
taxane
IBA
02/2001
1
Platinum
IBA
02/2001
1
A-Form DNA (A-DNA)
IBA
02/2001
1
Complementary DNA (cDNA)
IBA
09/2000
1
Endostatins
IBA
09/2000
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
05/2000
1
Prostate-Specific Antigen (Semenogelase)
IBA
05/2000
1
Angiostatins
IBA
05/2000
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
04/2000
1
Ceramides
IBA
04/2000
1
Sphingomyelin Phosphodiesterase (Sphingomyelinase)
IBA
04/2000
1
Cancer Vaccines
IBA
03/2000
1
chelerythrine
IBA
02/2000
1
Protein Kinase C
IBA
02/2000
1
Antineoplastic Agents (Antineoplastics)
IBA
02/2000
1
cemadotin (LU 103793)
IBA
01/2000
Therapy/Procedure
3
Therapeutics
01/2006 - 12/2000
2
Radiotherapy
04/2009 - 05/2000
1
Injections
12/2000
1
Aftercare (After-Treatment)
02/2000